J&J Unit's Topamax Warnings Were Inadequate, Jury Told

Law360, Philadelphia (March 4, 2014, 5:38 PM EST) -- A Johnson & Johnson unit's failure to warn doctors about the risks associated with the epilepsy medication Topamax resulted in a Wisconsin couple's child being born with birth defects, an attorney for the family told a jury during closing arguments in a Pennsylvania court trial on Tuesday.

David Matthews, an attorney with Matthews & Associates representing the family of 5-year-old Payton Anderson, told a jury in the Philadelphia County Court of Common Pleas that Janssen Pharmaceuticals Inc. had failed to update Topamax's label to reflect data...
To view the full article, register now.